Oestrogen receptor status and survival in Chinese females with breast cancer. 1982

T T Alagaratnam, and W I Wei, and S Y Cheung, and G B Ong

Oestrogen receptor assay was performed on one hundred and sixty-eight patients with proven breast cancer. Fifty-two per cent were positive for receptors; there was a lower incidence of positives in both the pre- and postmenopausal women, when compared with corresponding figures for American women. Patients were randomized into different modes of treatment. It was found that oestrogen receptor positive patients fared better than the negative ones irrespective of the stage of the disease or the treatment received, and this difference was statistically significant in patients with early disease (stages one and two). In patients assigned to some form of endocrine manipulation, 77% of receptor positive, and 7% receptor negative patients showed a response to treatment; in those receiving chemotherapy, receptor negative patients fared better than the positive ones, though the difference was not statistically significant.

UI MeSH Term Description Entries
D008408 Mastectomy Surgical procedure to remove one or both breasts. Mammectomy,Mammectomies,Mastectomies
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D010166 Palliative Care Care alleviating symptoms without curing the underlying disease. (Stedman, 25th ed) Palliative Treatment,Palliative Supportive Care,Palliative Surgery,Palliative Therapy,Surgery, Palliative,Therapy, Palliative,Care, Palliative,Palliative Treatments,Supportive Care, Palliative,Treatment, Palliative,Treatments, Palliative
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China

Related Publications

T T Alagaratnam, and W I Wei, and S Y Cheung, and G B Ong
February 2019, British journal of cancer,
T T Alagaratnam, and W I Wei, and S Y Cheung, and G B Ong
August 1979, Lancet (London, England),
T T Alagaratnam, and W I Wei, and S Y Cheung, and G B Ong
September 2009, Zhonghua zhong liu za zhi [Chinese journal of oncology],
T T Alagaratnam, and W I Wei, and S Y Cheung, and G B Ong
November 2020, British journal of cancer,
T T Alagaratnam, and W I Wei, and S Y Cheung, and G B Ong
June 1981, Lancet (London, England),
T T Alagaratnam, and W I Wei, and S Y Cheung, and G B Ong
July 1988, Irish journal of medical science,
T T Alagaratnam, and W I Wei, and S Y Cheung, and G B Ong
February 2011, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],
T T Alagaratnam, and W I Wei, and S Y Cheung, and G B Ong
April 1985, Lancet (London, England),
T T Alagaratnam, and W I Wei, and S Y Cheung, and G B Ong
September 1981, British journal of cancer,
T T Alagaratnam, and W I Wei, and S Y Cheung, and G B Ong
August 1986, The Journal of pathology,
Copied contents to your clipboard!